Skip to main content

Search

  • Bluesky
  • Facebook
  • LinkedIn
Home

Main navigation

  • About Us
    • About Us
    • Our Achievements
    • Clinical Advisory Group
    • Our Forum
    • Our Directors
    • Member Organisations
    • Corporate Sponsors
  • About Lung Cancer
    • About Lung Cancer
    • Lung Cancer in England
    • Lung Cancer in Northern Ireland
    • Lung Cancer in Scotland
    • Lung Cancer in Wales
    • Resources
    • Lung Cancer Nurse Specialists
    • Patient Information
  • Conference
    • Sponsors
    • Terms and Conditions
  • Reports
  • Blogs
  • Quality Improvements Hub

Driving Improvements in UK Lung Cancer

February 2024
Report on Driving Improvements in UK Lung Cancer
Report Download
UKLCC Report - Driving Improvements in UK Lung Cancer1.56 MB
Press Release
Sharing good practice 'critical' to UK lung cancer survival say experts

Footer menu

  • Contact
  • Disclaimer
  • Privacy Policy
  • Company Papers
  • Join Us
  • Press Releases
  • Login

The UKLCC is a private company limited by guarantee without share capital and incorporated as a Community Interest Company (CIC) registered at Companies House (Registration Number 11914752) and operating throughout the United Kingdom. VAT Registration Number 403495410 Phone: 01675 477605

Thank you to our corporate sponsors

AstraZenca
 ,
Boehringer Ingelheim
 ,
Bristol Myers Squibb
 ,
Lilly
 ,
MSD
 ,
Roche Products Limited

Our primary consideration in any collaboration with sponsors is ensuring that our independence is not in any way compromised and we are free to act in the best interests of healthcare professionals, the lung cancer community and people with lung cancer.

Sponsors have no influence or input into UKLCC policies, practices or resources produced. Reports are produced by UKLCC using independent medical writers. Editorial control for any reports produced by the organisation is held exclusively by UKLCC.

Sponsors have no input into the agenda of UKLCC conferences/events nor the selection of speakers. Representatives of pharmaceutical companies may attend UKLCC meetings in the capacity as observers.